Mechanically speaking, RNA immunoprecipitation (RIP) and RNA pull-down experiments indicated that in colorectal cancer cells, HULC promoted CRC by directly binding to EZH2 to inhibit the expression of NKD2 (62). The gene discussed is HULC; the disease is colorectal carcinoma.